The known bisalkylated 2,5-dihydroxybenzoquinones didemethylasterriquinone D and isocochliodinol as well as the new metabolites semicochliodinol A and B have been isolated as inhibitors of HIV-1 protease from the culture broth of the fungus Chrysosporium merdarium P-5656. The structures were elucidated by spectroscopic methods. The NMR spectra of two compounds were completely assigned. The metabolites inhibit HIV-1 protease with an IC50 value as low as 0. 17 fiM and epidermal growth factor receptor protein tyrosine kinase at 15 to 60^m and are therefore valuable lead compoundsfor these targets. Molecular modelling of the HIV-1-protease-inhibitor complexes showed hydrogen bonding between the dihydroxybenzoquinone moiety of didemethylasterriquinone D and isocochliodinol to both active-site aspartic acids (Asp25/Asp25') of the protease and the indole parts of the inhibitors filling the P2 and P2' pockets of the protease.
The known bisalkylated 2,5-dihydroxybenzoquinones didemethylasterriquinone D and isocochliodinol as well as the new metabolites semicochliodinol A and B have been isolated as inhibitors of HIV-1 protease from the culture broth of the fungus Chrysosporium merdarium P-5656. The structures were elucidated by spectroscopic methods. The NMR spectra of two compounds were completely assigned. The metabolites inhibit HIV-1 protease with an IC50 value as low as 0. 17 fiM and epidermal growth factor receptor protein tyrosine kinase at 15 to 60^m and are therefore valuable lead compoundsfor these targets. Molecular modelling of the HIV-1-protease-inhibitor complexes showed hydrogen bonding between the dihydroxybenzoquinone moiety of didemethylasterriquinone D and isocochliodinol to both active-site aspartic acids (Asp25/Asp25') of the protease and the indole parts of the inhibitors filling the P2 and P2' pockets of the protease.
Natural products are a continuous and proven source of new lead compounds to drug discovery programs.
Recently we pursued a drug discovery program aimed at the identification of inhibitors of the HIV-1 protease. Inhibitors of this enzyme have been shown to be clinically useful agents for AIDS therapy1*. In our search for inhibitors of the HIV-1 protease among secondary metabolites of microorganisms, inhibitors from the fungus Chrysosporium merdarium P-5656 were identified. The same compoundshad been identified in our earlier work as inhibitors of epidermal growth factor receptor protein tyrosine kinase (EGF-R PTK). PTK's are a family of enzymes catalyzing phosphorylation of tyrosine residues of protein substrates. The deregulation of PTK activity in tumor cells is associated with malignant transformation2^Inhibitors of EGF-R PTK could have a therapeutic potential as anticancer agents3). In the present communication, the taxonomy of the strain P-5656 and the production, isolation, structure elucidation and enzyme-inhibitory properties of didemethylasterriquinone D (1), isocochliodinol (2) as well as of the new compoundsnamedsemicochliodinol A and B (3 and 4) are described.
Materials and Methods

Microorganism : Isolation and Preservation
The fungal strain P-5656 was isolated from a soil sample collected in a coconut grove near Tenacatita, Mexico and taxonomically classified as Chrysosporium 395 merdarium. The microorganism was grown on LCSB agar (lactose 1.5%, cornsteep liquor 0.5%, peptone 0.5%, NaCl 0.4%, MgSO4-7H2O 0,05%, KH2PO4 0.06%, FeCl3 -6H2O 0.0005%, CuSO4-5H2O 0.0002%, agar 3.0%). The pH was adjusted to 4.8 with 5n H2SO4 or 5n NaOH). The fungus was incubated at 28°C for ten days until complete sporulation. Working stocks are stored at 4°C, whereas long-term storage is at -80°C and -196°C, respectively.
Fermentation
A mature slant culture of the strain P-5656 was inoculated into a 500-ml Erlenmeyer flask with 1 baffle containing 100 ml of a medium with following composition: glucose 2.0%, Pharmamedia (Traders Protein, Southern Cotton Oil Company, Memphis, U.S.A.) 1.5%, (NH4)2SO4 0.3%, ZnSO4-7H2O 0.003%, CaCO3 0.4%. Before sterilization, the pH was adjusted to 7.0. The culture was shaken under aerobic conditions for 48 hours at 28°C and 250rpm. 5ml of the seed culture were transferred into 500 ml of the above medium in a 2000-ml Erlenmeyer flask with four baffles. The vegetative culture was incubated under the same conditions as already described. 5.0% of the second seed culture was transferred into a 3.5-liter fermenter (MBRBioreactor AG, Wetzikon, Switzerland) filled with 2 liters of the following production medium: glucose 2.0%, potato starch 1.0%, soybean meal (defatted) 2.5%, yeast extract (Difco) 0.4%, meat extract (Difco) 0.1%, NaCl 0.25%. Prior to sterilization, the pH was adjusted to 7.0. The fermentation was run for 128 hours at a temperature of28°C, an aeration rate of 2 liters/minute and an agitation rate of 700rpm. A typical fermentation profile of the strain Chrysosporium merdarium P-5656 is shown in Fig. 1 Half of that material (68.5g) was dissolved in 50ml MeOHand applied on a fractogel TSKHW-40(F) column (column size 1470ml, flow 7 ml/minute) developed with MeOHyielding fraction 1 (3.2 liters to 4.9 liters, 5.90g) and fraction 2 (4.9 liters to 6.5 liters, 4.63 g).
Fraction 1 was recrystallized in 50ml MeOH to give isocochliodinol 2 (3.19 g) as black crystals.
Fraction 2 was dissolved in 30ml MeOH-acetone, (9 : 1) upon heating, added to LiChroprep RP-18 (10g) and adsorbed by addition of H2O (30ml). A portion of this material was filled in a precolumn attached to a conically shaped Buchi column and was chromatographed in four runs on reversed phase (300ml; LiChroprep RP-18, 15~25jmi, solvent A: water-TFA, The compoundswere tested for inhibition of the HIV-1 protease4), human cathepsin D4) and EGF-R PTK5'6) as described previously.
Molecular Modelling into HIV-1 Protease
Molecular modelling of the HIV-1-protease-inhibitor complexes was performed using Monte Carlo docking combined with substructure minimizations using MacroModel software V4.07). This procedure proved to yield geometries very close to the structures determined by X-ray for a variety of compounds8'9).
Modelling of 1 and 2 started with the X-ray structure of the CGP53437-HIV-1-protease complex9). The compounds were manually placed into the active site and preminimized in the rigid cavity for 1000 iterations. Then a Monte Carlo search (MCMM) was performed over 3000 steps, treating the chosen active site fragment of the protein (residues 8, 23, 25, 27-30, 32, 47-50, 76, 80-82, 84 ) with a constraint of lOkcal/mol and using (Table I ). The correlation of the shifts of the protonated 13C atoms of2 and 3 with those of the attached protons has been made with a PFG-HSQC(pulsed field gradient heteronuclear single quantumcoherence) experiment1 1}.
Heteronuclear multiple-bond connectivities (HMBC) between protons and carbons12) have been used to assign the quaternary carbon signals of 2 and 3. Structures of3 and 4 3 and 4 (Table 1) showed the signals of compound 1, Both compounds had a molecular composition of but the signals of the symmetric indole rings in 1 were C27H23N2C>4as determined by HR-MSsuggesting a split into pairs and one proton was missing. In addition C5H8unit in addition to structure 1. The XHNMRof the typical signals of a dimethylallyl side chain were visible. These findings suggested that 3 and 4 had the same core structure as didemethylasterriquinone D (1) and were substituted on two different positions on one of the two indole rings of 1 with a dimethylallyl side chain. In the XH NMRof both compounds the substituted indole ring shows a singlet and two doublet signals suggesting substitution at 5' and 6', respectively. Analysis of *H NMRand 13C NMRdata reveal that semicochliodinol B has the same substitution as isocochliodinol (2) and must have structure 4. Therefore semicochliodinol A must have structure 3 which was confirmed by analysis of the 13C NMRand *H NMR by HSQCand HMBC.
Fermentation and Isolation Didemethylasterriquinone D (1) has been described as a semisynthetic derivative of asterriquinone D13), a metabolite of Aspergillus terreus1^with in vivo anitumor activity15), but not as a microbial metabolite before.
Isocochliodinol 2 has been isolated from Chaetomium murorum10). Both symmetric compounds seem to be quite commonas fungal metabolites: From 3000 fungal strains screened in the assay for EGF-RPTKfive were shown to produce 1 and 2 belonging to various genua Gilmaniella humicola, Trichosporiella hyalina, Chaetomium sp., Botryotrichum piluliferum and Humicola grisea. Semicochliodinol A and B are produced only in small amounts. Analysis of the time course of product formation by HPLC (Fig. 1) showed that 3 was produced at a later stage of the fermentation. Molecular Modelling into HIV-1 Protease The HIV-1 protease is a homodimerwith symmetric pockets PI/PI' ; P2/P2' etc. for the side chains of the peptide/protein substrate. The dihydroxybenzoquinone moiety of compounds 1 and 2 allows hydrogen bonding to both active-site aspartic acids (Asp25/Asp25') and the two flap isoleucines (Ile50/Ile50') (Fig. 4) . This means that the critical water molecule, which is present in other HIV-1 protease inhibitor complexes and forms hydrogen bonds with the flaps as well as with the inhibitor atoms, is replaced by part of the inhibitor. This water replacement is similar to that observed with molecules such as 7-membered cyclic ureas16) or 4-hydroxypyrone derivatives17'18^which were specifically designed and later proved by X-ray to offer this feature. The indole parts of the molecules fill the P2 and P2' pockets of the protease (Fig. 5) . This was achieved differently in case of 1 than for the substituted compound 2. This because the 6/-dimethylallyl chain in 2 appears to be in an unfavorable position of the indole ring. When part of the substituted molecule is accommodatedin the binding site, the rest of the molecule is shifted away from the most favorable complex geometry. The different binding modes proposed by the molecular modelling were not reflected by differences in antienzymatic activities of compounds 1 and 2. Observation of the binding mode would be important for further chemical modifications of this class of compounds. According to this model, the Pl/Pl' and P3/P3' pockets are not filled at all. This allows interesting speculations, of how PI might be reached from the 2' or 4' position of the indole ring (e.g. by attaching a benzyl in one of these positions). The model obtained from the Monte Carlo docking studies can be used for subsequent structure-based drug design efforts.
Biological Properties
The compoundsare not light stable in dilute solutions. Their enzyme-inhibitory activity is shown in Table 2 . 
